Gender determinants of cardiovascular risk factors and diseases

Giuseppe Mercuro, Martino Deidda, Alessandra Piras, Christian Cadeddu Dessalvi, Silvia Maffei, Giuseppe M C Rosano

Research output: Contribution to journalArticle

67 Citations (Scopus)

Abstract

This article addresses the various aspects concerning gender dissimilarities in the cardiovascular system. It examines sex differences in the genetic susceptibility to cardiovascular disease (CVD) development or outcome: with the presence of either XX or XY chromosomes, every cell is sexually differentiated and there exist postpuberal differences between male and female cardiovascular systems. The main action mechanisms of sex steroid hormones are discussed, mainly as to testosterone (Te) in men and 17β-estradiol (E2) and progesterone (Pro) in women. In women, susceptibility to CVD is known to increase in the postmenopausal period, when the ovarian hormone function expires. Some concepts of the sex-based differences in anatomy and physiology are also explained. Although they have the same structural elements, women and men use them in a different way to guarantee cardiovascular system homeostasis. Some examples of differences between men and women in pathological cardiovascular function are given. A further important issue regards the prevalence and role of cardiovascular risk factors in the two genders. Compared to boys of the same age, adolescent girls and premenopausal women have a more favorable risk profile: lower blood pressure (BP), less atherogenic lipid profile, and lower prevalence of cardiovascular risk factors. Women develop CVD later than men and diabetic women have a considerably higher mortality rate compared to men of the same age. Finally, there exist several clinically significant differences between men and women as to prevalence, presentation, management and outcome of CVD. Clinical peculiarities related to gender in presentation of some CVDs, such as coronary heart disease (CHD), stroke and heart failure, are described. We are absolutely convinced that only an accurate knowledge of the sex-specific pathophysiology may allow determination of the appropriate diagnostic instruments and to implement tailored treatments of CVD in men and women.

Original languageEnglish
Pages (from-to)207-220
Number of pages14
JournalJournal of Cardiovascular Medicine
Volume11
Issue number3
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Cardiovascular Diseases
Cardiovascular System
Sex Characteristics
Postmenopause
Gonadal Steroid Hormones
Genetic Predisposition to Disease
Coronary Disease
Progesterone
Testosterone
Estradiol
Anatomy
Homeostasis
Heart Failure
Chromosomes
Stroke
Hormones
Blood Pressure
Lipids
Mortality
Therapeutics

Keywords

  • Cardiovascular disease
  • Gender
  • Genetics
  • Pathophysiology
  • Sex hormones

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Gender determinants of cardiovascular risk factors and diseases. / Mercuro, Giuseppe; Deidda, Martino; Piras, Alessandra; Dessalvi, Christian Cadeddu; Maffei, Silvia; Rosano, Giuseppe M C.

In: Journal of Cardiovascular Medicine, Vol. 11, No. 3, 03.2010, p. 207-220.

Research output: Contribution to journalArticle

Mercuro, Giuseppe ; Deidda, Martino ; Piras, Alessandra ; Dessalvi, Christian Cadeddu ; Maffei, Silvia ; Rosano, Giuseppe M C. / Gender determinants of cardiovascular risk factors and diseases. In: Journal of Cardiovascular Medicine. 2010 ; Vol. 11, No. 3. pp. 207-220.
@article{a4497daec0d144f1b063d165ba354494,
title = "Gender determinants of cardiovascular risk factors and diseases",
abstract = "This article addresses the various aspects concerning gender dissimilarities in the cardiovascular system. It examines sex differences in the genetic susceptibility to cardiovascular disease (CVD) development or outcome: with the presence of either XX or XY chromosomes, every cell is sexually differentiated and there exist postpuberal differences between male and female cardiovascular systems. The main action mechanisms of sex steroid hormones are discussed, mainly as to testosterone (Te) in men and 17β-estradiol (E2) and progesterone (Pro) in women. In women, susceptibility to CVD is known to increase in the postmenopausal period, when the ovarian hormone function expires. Some concepts of the sex-based differences in anatomy and physiology are also explained. Although they have the same structural elements, women and men use them in a different way to guarantee cardiovascular system homeostasis. Some examples of differences between men and women in pathological cardiovascular function are given. A further important issue regards the prevalence and role of cardiovascular risk factors in the two genders. Compared to boys of the same age, adolescent girls and premenopausal women have a more favorable risk profile: lower blood pressure (BP), less atherogenic lipid profile, and lower prevalence of cardiovascular risk factors. Women develop CVD later than men and diabetic women have a considerably higher mortality rate compared to men of the same age. Finally, there exist several clinically significant differences between men and women as to prevalence, presentation, management and outcome of CVD. Clinical peculiarities related to gender in presentation of some CVDs, such as coronary heart disease (CHD), stroke and heart failure, are described. We are absolutely convinced that only an accurate knowledge of the sex-specific pathophysiology may allow determination of the appropriate diagnostic instruments and to implement tailored treatments of CVD in men and women.",
keywords = "Cardiovascular disease, Gender, Genetics, Pathophysiology, Sex hormones",
author = "Giuseppe Mercuro and Martino Deidda and Alessandra Piras and Dessalvi, {Christian Cadeddu} and Silvia Maffei and Rosano, {Giuseppe M C}",
year = "2010",
month = "3",
doi = "10.2459/JCM.0b013e32833178ed",
language = "English",
volume = "11",
pages = "207--220",
journal = "Journal of Cardiovascular Medicine",
issn = "1558-2027",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Gender determinants of cardiovascular risk factors and diseases

AU - Mercuro, Giuseppe

AU - Deidda, Martino

AU - Piras, Alessandra

AU - Dessalvi, Christian Cadeddu

AU - Maffei, Silvia

AU - Rosano, Giuseppe M C

PY - 2010/3

Y1 - 2010/3

N2 - This article addresses the various aspects concerning gender dissimilarities in the cardiovascular system. It examines sex differences in the genetic susceptibility to cardiovascular disease (CVD) development or outcome: with the presence of either XX or XY chromosomes, every cell is sexually differentiated and there exist postpuberal differences between male and female cardiovascular systems. The main action mechanisms of sex steroid hormones are discussed, mainly as to testosterone (Te) in men and 17β-estradiol (E2) and progesterone (Pro) in women. In women, susceptibility to CVD is known to increase in the postmenopausal period, when the ovarian hormone function expires. Some concepts of the sex-based differences in anatomy and physiology are also explained. Although they have the same structural elements, women and men use them in a different way to guarantee cardiovascular system homeostasis. Some examples of differences between men and women in pathological cardiovascular function are given. A further important issue regards the prevalence and role of cardiovascular risk factors in the two genders. Compared to boys of the same age, adolescent girls and premenopausal women have a more favorable risk profile: lower blood pressure (BP), less atherogenic lipid profile, and lower prevalence of cardiovascular risk factors. Women develop CVD later than men and diabetic women have a considerably higher mortality rate compared to men of the same age. Finally, there exist several clinically significant differences between men and women as to prevalence, presentation, management and outcome of CVD. Clinical peculiarities related to gender in presentation of some CVDs, such as coronary heart disease (CHD), stroke and heart failure, are described. We are absolutely convinced that only an accurate knowledge of the sex-specific pathophysiology may allow determination of the appropriate diagnostic instruments and to implement tailored treatments of CVD in men and women.

AB - This article addresses the various aspects concerning gender dissimilarities in the cardiovascular system. It examines sex differences in the genetic susceptibility to cardiovascular disease (CVD) development or outcome: with the presence of either XX or XY chromosomes, every cell is sexually differentiated and there exist postpuberal differences between male and female cardiovascular systems. The main action mechanisms of sex steroid hormones are discussed, mainly as to testosterone (Te) in men and 17β-estradiol (E2) and progesterone (Pro) in women. In women, susceptibility to CVD is known to increase in the postmenopausal period, when the ovarian hormone function expires. Some concepts of the sex-based differences in anatomy and physiology are also explained. Although they have the same structural elements, women and men use them in a different way to guarantee cardiovascular system homeostasis. Some examples of differences between men and women in pathological cardiovascular function are given. A further important issue regards the prevalence and role of cardiovascular risk factors in the two genders. Compared to boys of the same age, adolescent girls and premenopausal women have a more favorable risk profile: lower blood pressure (BP), less atherogenic lipid profile, and lower prevalence of cardiovascular risk factors. Women develop CVD later than men and diabetic women have a considerably higher mortality rate compared to men of the same age. Finally, there exist several clinically significant differences between men and women as to prevalence, presentation, management and outcome of CVD. Clinical peculiarities related to gender in presentation of some CVDs, such as coronary heart disease (CHD), stroke and heart failure, are described. We are absolutely convinced that only an accurate knowledge of the sex-specific pathophysiology may allow determination of the appropriate diagnostic instruments and to implement tailored treatments of CVD in men and women.

KW - Cardiovascular disease

KW - Gender

KW - Genetics

KW - Pathophysiology

KW - Sex hormones

UR - http://www.scopus.com/inward/record.url?scp=76449120222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76449120222&partnerID=8YFLogxK

U2 - 10.2459/JCM.0b013e32833178ed

DO - 10.2459/JCM.0b013e32833178ed

M3 - Article

C2 - 19829128

AN - SCOPUS:76449120222

VL - 11

SP - 207

EP - 220

JO - Journal of Cardiovascular Medicine

JF - Journal of Cardiovascular Medicine

SN - 1558-2027

IS - 3

ER -